Baseline Mutational Patterns and Sustained MRD Negativity in Patients With High-Risk Smoldering Myeloma

Blood advances - United States
doi 10.1182/bloodadvances.2017005934
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

American Society of Hematology

Related search

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Four Genes Predict High Risk of Progression From Smoldering to Symptomatic Multiple Myeloma (SWOG S0120)

Haematologica
Hematology
2015English

Treatment Patterns and Outcomes in Elderly Patients With Multiple Myeloma,

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America
OncologyHematology
2007English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Smoldering Multiple Myeloma: Prevalence and Current Evidence Guiding Treatment Decisions

Blood and Lymphatic Cancer: Targets and Therapy
2018English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy